中文 | English
Return
Total: 42 , 1/5
Show Home Prev Next End page: GO
Author:( Fandian, ZENG)

1.Development and application of models for screening torsade de pointes induced by drugs

Qiangni LIU ; Fandian ZENG

Chinese Pharmacological Bulletin 2003;0(07):-

2.Inhibitory effect of β-aescin on inflammatory process following focal cerebral ischemia-reperfusion in rats

Xiamin HU ; Fandian ZENG

Chinese Journal of Pharmacology and Toxicology 2005;19(1):1-6

3.Efficacy and safety of metoclopramide and ondansetron in preventing nausea and vomiting induced by chemotherapy or operation: a meta-analysis

Changkai YAN ; Fandian ZENG

Chinese Journal of Digestion 2001;0(09):-

4.Protective effects of breviscapine on myocardial hypertrophy and fibrosis induced by isoproterenol in rats

Wei HE ; Fandian ZENG

Chinese Pharmacological Bulletin 2003;0(12):-

5.Essential Drug and Pharmacoepidemiology

Fandian ZENG ; Jianhong WU

China Pharmacy 2005;0(20):-

6.Reactivative effect of neferine on the poisoning mice of cholinesterase with organophosphate

Yuqing XIONG ; Fandian ZENG ;

Chinese Pharmacological Bulletin 1986;0(06):-

7.Effects of non-dependent antiepileptic agents on addiction disease

Shaojian YE ; Fandian ZENG ;

Chinese Pharmacological Bulletin 1987;0(02):-

8.The inhibitory effects on the growth of human hepatocellular carcinoma cell and its mechanism by theasinesin

Huawen XIN ; Fandian ZENG ; Bijun XIE

Chinese Pharmacological Bulletin 2001;17(1):37-40

9.EFFECTS OF DAURlCINE ON THE ELECTROPHYSIOLOGICAL CHARACTERISTICS AND ARRHYTHMIA INDUCED BY ACUTE CORONARY ARTERY LIGATION AND REPERFUSION IN ANESTHETIZED CATS

Jiequan ZHU ; Fandian ZENG ; Chongjia HU

Chinese Pharmacological Bulletin 1987;0(01):-

10.The inhibitory effects on the growth of human hepatocellular carcinoma cell and its mechanism by theasinesin

Huawen XIN ; Fandian ZENG ; Bijun XIE ;

Chinese Pharmacological Bulletin 1987;0(01):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 42 , 1/5 Show Home Prev Next End page: GO